The cell death of C6 astrocytoma cells induced by oridonin and its mechanism

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 6, 2012, Pages 562-568

  Yin, Bo ^a   Sheng, Hansong ^a   Lin, Jian ^a   Zhou, Hui ^a   Zhang, Nu ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Astrocytoma; C6 astrocytoma cells; Cell death; Oridonin

Indexed keywords

ANTINEOPLASTIC AGENT; BAX PROTEIN, RAT; CASP3 PROTEIN, RAT; CASPASE 3; KAURANE DERIVATIVE; ORIDONIN; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL; APOPTOSIS; ARTICLE; ASTROCYTOMA; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG SCREENING; FLOW CYTOMETRY; METABOLISM; MITOCHONDRION; PATHOLOGY; RAT; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; ASTROCYTOMA; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DITERPENES, KAURANE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; TIME FACTORS;

EID: 84866011938     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Aoki H, Kakinuma K, Morita K, Kato M, Uzuka T, Igor G, Takahashi H, Tanaka R. Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: evaluation of drug distribution in a rat glioma model. Int J Hyperthermia 2004 Sep; 20: 595-605.
2. Abelson PH. Medicine from plants. Science 1990; 247: 513.
3. Fujita E, Katayama H, Shibuya M. Oridonin, a new diterpenoid from isodon. Species Chem Commun 1967; 252.
4. Ren KK, Wang HZ, Xie LP, Chen DW, Liu X, Sun J, Nie YC, Zhang RQ. The effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cells. J Ethnopharmacol 2006; 103: 176-180.
5. Chen S, Gao J, Halicka HD, Huang X, Traganos F, Darzynkiewicz Z. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage. Int J Oncol 2005; 26: 579- 588.
6. Hsieh TC, Wijeratne EK, Liang JY, Gunatilaka AL, Wu JM. Differential control of growth, cell cycle progression, and expression of NFkappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb Rabdosia rubescens. Biochem Biophys Res Commun 2005; 337: 224-231.
7. Liu YQ, Mu ZQ, You S, Tashiro S, Onodera S, Ikejima T. Fas/FasL signaling allows extracellular-signal regulated kinase to regulate cytochrome c release in oridonininduced apoptotic U937 cells. Biol Pharm Bull 2006; 29: 1873-1879.
8. Zhang CL, Wu LJ, Zuo HJ, Tashiro S, Onodera S, Ikejima T. Cytochrome c release from oridonintreated apoptotic A375-S2 cells is dependent on p53 and extracellular signal-regulated kinase activation. J Pharmacol Sci 2004; 96: 155-163.
9. Li D, Cui Q, Chen SG, Wu LJ, Tashiro S, Onodera S, Ikejima T. Inactivation of ras and changes of mitochondrial membrane potential contribute to oridonin-induced autophagy in a 431 cells. J Pharmacol Sci 2007; 105: 22-33.
10. Wang H, Ye Y, Pan SY, Zhu GY, Li YW, Fong DW, Yu ZL. Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells. Phytomedicine 2011; 18: 163-169.
11. Cheng Y, Qiu F, Ye YC, Tashiro S, Onodera S, Ikejima T. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells. Arch Biochem Biophys 2009; 490: 70- 75.
12. Lou H, Gao L, Wei X, Zhang Z, Zheng D, Zhang D, Zhang X, Li Y, Zhang Q. Oridonin nanosuspension enhances antitumor efficacy in SMMC-7721 cells and H22 tumor bearing mice. Colloids Surf B Biointerfaces 2011; 87: 319-325.
13. Hu HZ, Yang YB, Xu XD, Shen HW, Shu YM, Ren Z, Li XM, Shen HM, Zeng HT. Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line. Acta Pharmacol Sin 2007; 28: 1819-1826.
14. Cui Q, Tashiro S, Onodera S, Minami M, Ikejima T. Oridonin induced autophagy in human cervical carcinoma HeLa cells through Ras, JNK and P38 regulation. J Pharmacol Sci 2007; 105: 317-325.
15. Benda P, Lightbody J, Sato G, Levine L, Sweet W. Differentiated rat glial cell strain in tissue culture. Science 1968 Jul 26; 161: 370-1.
16. Sibenaller ZA, Etame AB, Ali MM, Barua M, Braun TA, Casavant TL, Ryken TC. Genetic characterization of commonly used glioma cell lines in the rat animal model system. Neurosurg Focus 2005 Oct 15; 19: E1.
17. Barth RF, Kaur B. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.J Neurooncol 2009 Sep; 94: 299-312.
18. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-11.
19. Buttyan R, Gobé G. Apoptosis in the mammalian kidney: incidence, effectors, and molecular control in normal development and disease states. Adv Pharmacol 1997; 41: 369-81.
20. Schultz DR, Harrington WJ Jr. Apoptosis: programmed cell death at a molecular level.Semin Arthritis Rheum 2003 Jun; 32: 345-69.
21. Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999 Feb; 6: 99-104
22. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997; 3: 614-9.
23. Cory S, Adams JM. Killing cancer cells by flipping the Bcl-2/Bax switch. Cancer Cell 2005 Jul; 8: 5-6.